About-cancer/treatment/drugs/defibrotide-sodium/zh

去纖蛋白鈉

該頁面包含有關去纖蛋白鈉的簡要信息，以及一些連結，這些連結指向有關該藥物的使用，研究結果和正在進行的臨床試驗的更多信息。

美國品牌名稱

Defitelio

FDA 批准

是

該藥物的FDA標籤信息可從DailyMed獲得。

用於癌症

去纖蛋白鈉被批准用於治療：

• 肝靜脈閉塞性疾病 成人和兒童（也稱為正弦竇阻塞綜合徵）在接受幹細胞移植後也有腎臟或肺部疾病。

更多關於去纖蛋白鈉

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Defibrotide Sodium - A lay language summary of important information about this drug that may include the following:

• warnings about this drug,

• what this drug is used for and how it is used,

• what you should tell your doctor before using this drug,

• what you should know about this drug before using it,

• other drugs that may interact with this drug, and

• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials Accepting Patients

Find Clinical Trials for Defibrotide Sodium - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.